Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC

Clinical trial NCT06861777 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06861777
Sponsor: YIN LI
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma (ESCC)

Start date: 2025-03-01
Primary completion: 2031-05-01
Enrollment: 474

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.